Potential new lead compounds for treatment of depression and anxiety disorders
Currently, various classes of drugs are available for the treatment of mental illnesses - such…
November 15, 2022 - 3 minutes
mental health issues
Sensorium closes $30M deal to advance drug discovery engine
Sensorium Therapeutics, announced the closing of a $30 million series a financing to advance its…
November 9, 2022 - 3 minutes
Study of injection to treat schizophrenia to begin after $3M payment received
A phase 3 clinical trial for an injection to treat patients with schizophrenia has been…
September 1, 2022 - 2 minutes
Freedom Biosciences exits stealth with $10.5M financing to develop mental health treatments
Freedom Biosciences, a U.S. clinical-stage biotech platform developing ketamine and psychedelic therapeutics, today emerged from…
August 23, 2022 - 3 minutes
Paradigm of treatment of mental health to be transformed by gut-brain development program
Building on a decade of research, a development program for next-generation probiotics and therapeutics to…
July 13, 2022 - 3 minutes
Sanofi sells two portfolios of established products to Neuraxpharma
Two drugs portfolios with products to treat the central nervous system, pain and vascular disease…
July 13, 2022 - 2 minutes
Positive news from trial for drug to treat major depressive disorder
A company working on treatments for people with mental health issues has had positive feedback…
July 5, 2022 - 3 minutes
